Lrrk1 Leucine Rich Repeat Kinase 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
LRRK1 (Leucine-Rich Repeat Kinase 1) is a large multi-domain protein kinase related to LRRK2 (Parkin-linked kinase). It is encoded by the LRRK1 gene located on chromosome 15q26.3 and is expressed in various tissues including the brain, with particularly high expression in osteoclasts and neurons.
| LRRK1 | |
|---|---|
| Gene Symbol | LRRK1 |
| Full Name | Leucine-Rich Repeat Kinase 1 |
| Chromosome | 15q26.3 |
| NCBI Gene ID | 120892 |
| Ensembl ID | ENSG00000153902 |
| UniProt ID | Q8IWU6 |
| Protein Length | 2,023 amino acids |
| Molecular Weight | ~230 kDa |
LRRK1 is a member of the ROCO family of proteins and contains multiple functional domains:
| Domain | Position | Function |
|---|---|---|
| Leucine-Rich Repeats (LRR) | N-terminal | Protein-protein interactions, substrate recognition |
| Ras of Complex (ROC) | Central | GTPase activity, dimerization |
| COR | Central | C-terminal of ROC, regulates GTPase |
| Kinase Domain | C-terminal | Serine/threonine phosphorylation |
| WD40 Repeats | C-terminal | Protein scaffolding, localization |
LRRK1 possesses dual enzymatic activities:
LRRK1 may play roles in PD pathophysiology:
LRRK1 and LRRK2 are related kinases but have distinct functions:
| Model | Phenotype | Relevance |
|---|---|---|
| LRRK1 knockout mice | Viable, bone abnormalities | Lysosomal dysfunction |
| LRRK1 knockdown | Altered dopamine signaling | PD research |
| LRRK1 kinase-dead | Protein mislocalization | Drug development |
| Approach | Mechanism | Development Stage |
|---|---|---|
| Small molecule inhibitors | Block kinase activity | Research |
| GTPase modulators | Regulate ROC domain function | Preclinical |
| ASO therapy | Knockdown expression | Preclinical |
| Gene therapy | Restore functional LRRK1 | Future |
| Disease | Role | Evidence |
|---|---|---|
| Parkinson's Disease | Risk factor, lysosomal function | GWAS, PD models |
| Osteoporosis-parkinsonism syndrome | Bone metabolism | LRRK1 mutations cause bone disease |
| Neurodegeneration | Protein quality control | Cellular models |
LRRK1 is expressed in multiple brain regions:
The study of Lrrk1 Leucine Rich Repeat Kinase 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.